Shares of Universal Biosensors, Inc. (ASX:UBI) dropped 5% during trading on Tuesday . The stock traded as low as A$0.19 ($0.13) and last traded at A$0.19 ($0.13), approximately 7,499 shares traded hands during trading. A decline of 89% from the average daily volume of 66,890 shares. The stock had previously closed at A$0.20 ($0.14).
The firm has a market capitalization of $33.73 million and a PE ratio of 0.99. The company’s 50-day simple moving average is A$0.21 and its 200 day simple moving average is A$0.21. The company has a quick ratio of 7.82, a current ratio of 8.43 and a debt-to-equity ratio of 38.01.
About Universal Biosensors (ASX:UBI)
Universal Biosensors, Inc, through its subsidiary, Universal Biosensors Pty Ltd, operates as a medical diagnostics company in Australia. It focuses on the research, development, and manufacture of in vitro diagnostic test devices for consumer and professional point-of-care use. The company uses electrochemical cell technology platform to develop point-of-care testing systems for various markets.
Featured Article: Commodities
Receive News & Ratings for Universal Biosensors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Biosensors and related companies with MarketBeat.com's FREE daily email newsletter.